Skip to main content

Table 1 Mean absolute and proportional change in the use of diagnostic tests per patient

From: Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis

 

Negative

Physician-directed Protocol /Normal

Physician-directed Protocol /Positive

Δ (95% CI)

Δ%

Δ (95% CI)

Δ%

Δ (95% CI)

Δ%

Total

−0.686 (− 0.854, − 0.517)*

−41

− 0.208 (− 0.488, 0.072)

−11

0.722 (0.265, 1.179)*

+ 38

Invasive

−0.519 (− 0.639, − 0.399)*

−51

− 0.198 (− 0.397, 0.001)

−17

0.639 (0.314, 0.963)*

+ 55

Cystoscopy

 Flexible

−0.352 (− 0.422, − 0.283)*

− 56

0.187 (− 0.303, − 0.072)

−28

0.000 (− 0.188, 0.188)

0

 Rigid

0.000 (− 0.021, 0.021)

0

0.031 (− 0.004, 0.067)

+ 300

0.250 (0.192, 0.308)*

+ 900

CT scan

 Contrast

−0.155 (− 0.214, − 0.096)*

−48

−0.031 (− 0.129, 0.067)

−8

0.361 (0.201, 0.521)*

+ 100

 Non-contrast

−0.011 (− 0.043, 0.020)

−16

−0.010 (− 0.063, 0.042)

−13

0.028 (− 0.058, 0.113)

+ 25

Non-invasive tests

 Ultrasound

0.034 (−0.022, 0.090)

+ 11

0.083 (−0.009, 0.176)

+ 26

− 0.056 (− 0.207, 0.096)

−18

 Urine cytology

− 0.170 (− 0.229, − 0.112)

− 60

− 0.062 (− 0.159, 0.034)

−18

0.167 (0.009, 0.325)*

+ 43

 UroVysion® FISH

−0.030 (− 0.051, − 0.009)*

−100

−0.031 (− 0.066, 0.004)

− 75

−0.028 (− 0.085, 0.029)

−50

  1. *p < 0.05
  2. Abbreviations: CT computed tomography, FISH fluorescence in situ hybridization